Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: Tob Control. 2012 Sep 25;22(6):e11. doi: 10.1136/tobaccocontrol-2012-050465

Cost-effectiveness of internet and telephone treatment for smoking cessation: an economic evaluation of The iQUITT Study

Amanda L Graham 1,2, Yaojen Chang 2, Ye Fang 1, Nathan K Cobb 1,2,3,4, David S Tinkelman 5, Raymond S Niaura 1,2,4, David B Abrams 1,2,4, Jeanne S Mandelblatt 2
PMCID: PMC3626730  NIHMSID: NIHMS423215  PMID: 23010696

Abstract

Background

Internet and telephone treatments for smoking cessation can reach large numbers of smokers. There is little research on their costs and the impact of adherence on costs and effects.

Objective

To conduct an economic evaluation of The iQUITT Study, a randomised trial comparing Basic Internet, Enhanced Internet and Enhanced Internet plus telephone counselling (‘Phone’) at 3, 6, 12 and 18 months.

Methods

We used a payer perspective to evaluate the average and incremental cost per quitter of the three interventions using intention-to-treat analysis of 30-day single-point prevalence and multiple-point prevalence (MPP) abstinence rates. We also examined results based on adherence. Costs included commercial charges for each intervention. Discounting was not included given the short time horizon.

Results

Basic Internet had the lowest cost per quitter at all time points. In the analysis of incremental costs per additional quitter, Enhanced Internet+Phone was the most cost-effective using both single and MPP abstinence metrics. As adherence increased, the cost per quitter dropped across all arms. Costs per quitter were lowest among participants who used the ‘optimal’ level of each intervention, with an average cost per quitter at 3 months of US$7 for Basic Internet, US$164 for Enhanced Internet and US$346 for Enhanced Internet +Phone.

Conclusions

‘Optimal’ adherence to internet and combined internet and telephone interventions yields the highest number of quitters at the lowest cost. Cost-effective means of ensuring adherence to such evidence-based programmes could maximise their population-level impact on smoking prevalence.

INTRODUCTION

Cigarette smoking remains the leading cause of preventable death in the USA, claiming 443,000 lives and costing approximately US$193 billion annually (all $ values given are US$).1 Despite effective behavioural and pharmacological treatments,2 about 44 million Americans continue to smoke, and the decline in smoking prevalence has stalled, with smoking rates hovering around 20% since 2004.3 Accelerating the reduction in the prevalence of smoking will require innovative approaches to deliver cost-effective cessation interventions at the population level.46

Internet and telephone interventions have great potential to impact smoking prevalence given their broad reach and accessibility.2 More than 80% of US adults are internet users,7 and over 10 million adults search for cessation information annually.8,9 A growing number of randomised trials and meta-analyses of internet interventions provide evidence of effectiveness,1012 but there are only a few studies of their cost-effectiveness.13 Telephone counselling is effective2 and cost-effective,14,15 and ‘quitline’ services are available throughout the USA. Adding proactive telephone counselling to internet interventions (or vice versa) may further improve population impact at reasonable cost. Most US quitlines offer internet services,16,17 but there is limited evidence about the effectiveness and cost-effectiveness of combined treatment.1821

A critical parameter to consider in cost-effectiveness analyses is adherence,22 though it remains inconsistently evaluated and reported.23 The importance of adherence to treatment outcome is well documented.24,25 Adherence is traditionally defined as ‘the extent to which a person’s behaviour corresponds with agreed recommendations from a healthcare provider’.25 Since internet and telephone interventions have no specified prescriptions for use, adherence, in this context, may best be defined as ‘the extent to which individuals experience the content of the intervention’.26 Adherence is low across internet studies, with a majority of participants using interventions minimally or not at all.27,28 Telephone counselling adherence is also lower in real-world practice.29,30

Poor adherence in internet and telephone trials may have significant implications for cost-effectiveness because there is a well documented dose-response relationship between cessation treatments and abstinence, with greater treatment intensity associated with higher quit rates.2 Including participants who use an intervention minimally or not at all in cost-effectiveness analyses, may result in incomplete and/or misleading interpretations of cost-effectiveness results. We are aware of no cost-effectiveness studies that have addressed adherence in trials of internet and telephone cessation interventions.

The purpose of this study was to conduct an economic evaluation of The iQUITT Study,31 a randomised trial of internet and telephone treatment for smoking cessation, and to examine the impact of treatment adherence on cost-effectiveness. These data can be used to inform decisions about intervention delivery, and to highlight the importance of adherence as an important consideration for future research.

METHODS

Overview of The iQUITT study

The iQUITT Study was a three-group randomised trial (clinicaltrials.gov NCT00282009) that compared the effectiveness of an Enhanced Internet smoking cessation programme—alone and in combination with integrated, proactive, telephone counselling—with a Basic Internet comparison condition. The study has been described elsewhere.31,32 Briefly, US smokers were recruited between 2005 and 2007 using active user interception sampling. Consistent with recommendations for reporting standardised cessation outcomes,33 and to allow for comparisons with other published studies, the primary outcomes were self-reported 30-day single-point prevalence (SPP) abstinence, and 30-day multiple-point prevalence (MPP) abstinence (abstinence at a particular follow-up and all prior time points) measured at 3, 6, 12 and 18 months post-randomisation. Abstinence rates were calculated using intention-to-treat analysis which counted participants lost to follow-up as smoking. Biochemical verification of abstinence was not feasible or recommended since this was a national sample enrolled through the internet.34 All participants provided informed consent, and the study was approved by the Georgetown University Institutional Review Board (protocol #2006-409).

Interventions

Participants randomised to Enhanced Internet were provided 6 months of free access to QuitNet.com, a widely used and longstanding commercial smoking cessation internet programme.31,35,36 QuitNet provides advice and assistance in accordance with evidence-based guidelines, and includes interactive features and a large online social network. Participants randomised to Enhanced Internet plus proactive telephone counselling (Enhanced Internet+Phone) received 6 months free access to QuitNet and proactive telephone counselling provided by trained cessation counsellors at National Jewish Health. Telephone counselling was seamlessly integrated with QuitNet; counsellors delivered the standard National Jewish five-call protocol and reinforced and encouraged use of QuitNet. In the Basic Internet condition, participants were provided 6 months of free access to static content extracted from QuitNet, including quitting and medication guides, a national directory of cessation programmes, and responses to ‘Frequently Asked Questions’. The Basic Internet site was created for this trial as a minimal intervention comparison condition; it had no interactive features and no online social network.

The study was designed largely as a pragmatic randomised trial37 to maximise generalisability and real-world relevance while preserving internal validity. We evaluated each intervention as used in the real world, with the goal of bridging the gap between tightly controlled clinical research and the applicability of research in practice. There were no incentives or other strategies to boost adherence.

Data collection

At each follow-up, research staff contacted participants by telephone to assess abstinence and other outcomes. Individuals not reached via telephone were emailed a link to an online survey. Participants were paid only for completing follow-up surveys ($25 online, $15 telephone).

Website utilisation metrics common to Basic and Enhanced Internet (logins, page views, minutes on the website, content used) were extracted from host servers; participation in the online social network (eg, number of QuitNet members to whom the participant sent messages) was extracted for those in Enhanced Internet. Telephone counsellors used a web-based tool to record the number, duration and content of calls.

Cost-effectiveness

The economic analysis followed published guidelines.38,39 Since smoking cessation results in improved survival and quality-adjusted life years compared with continued smoking,2 we did not use life years saved as an outcome metric. Instead, we used conventions in comparable tobacco control studies19,40 to evaluate the average cost per quitter. We also calculated the incremental cost per additional quitter using a payer perspective since our goal was to inform decisions about widespread intervention delivery to large populations by insurers and other payers. The time horizon of the analysis was limited to the study period of 18 months post-randomisation, so we did not discount costs or effects. Costs were the commercial charges for each intervention. We did not include pharmacotherapy costs since medication was not provided to the study participants, its use was equally distributed across arms at baseline and at 3 months, use was not related to 3-month abstinence (p=0.2778), and there were no differential effects of pharmacotherapy use on abstinence by treatment arm (p=0.5406).

We also examined the impact of adherence on cost-effectiveness by considering the number of quitters in each arm by actual use of the interventions. We focused on participants who did not use the intervention at all, and participants whose level of treatment utilisation exceeded a certain threshold which we designated as ‘optimal’. We examined 3-month utilisation and follow-up data since adherence was highest during the initial months of the study. We defined adherence based on three utilisation metrics: (1) treatment intensity (all three arms); (2) online community involvement (Enhanced Internet and Enhanced Internet+Phone arms only) and (3) telephone counselling use (Enhanced Internet+Phone). We used empirical data to identify thresholds where a significant dose-response relationship has been reported. For treatment intensity, ‘optimal’ adherence was defined as use of the assigned internet intervention for 30 min or more based on a meta-analysis demonstrating that the odds of cessation increase more than threefold when intervention contact time exceeds 30 min.2 For online community involvement, ‘optimal’ adherence was defined as sending messages to one or more QuitNet members based on our previous research35 which showed that communication with other QuitNet members differentiated quitters from current smokers. Finally, ‘optimal’ adherence for telephone counselling was defined as completing five or more calls since this is standard protocol,41 and there is a dose-response relation between sessions and treatment effectiveness.2

Effects

The primary effectiveness measure was the number of quitters at each follow-up, with abstinence defined as 30-day SPP and MPP abstinence based on intention to treat. Since the arms were balanced with respect to demographics, smoking profiles and use of pharmacotherapy, we used unadjusted effects for all analyses. Adherence analyses only consider 30-day SPP and MPP abstinence at 3 months since treatment utilisation was highest during the initial months of the study and tailed off significantly after 3 months.

Assignment of costs for intervention arms

The Basic Internet condition was designed to mirror the majority of publicly available (free) cessation websites, most of which contain static information.42 The challenge in estimating the costs per user for Basic Internet is that while many of the elements may be ‘known’ (eg, fixed development costs, hosting fees), the number of users is unknown. Were we to calculate the cost of Basic Internet as the known costs to develop and maintain the trial site divided by the number of Basic Internet study participants (n=679), the results would be inappropriately high. On the other hand, were we to assume the existence of a large-scale public health campaign driving people to the site (eg, up to 1 000 000 visitors/year in the BecomeAnEX campaign43), the cost would approach pennies per individual (excluding campaign costs). Thus, we assigned an estimated $1 per user as a reasonable real-world cost to a payer to provide static web pages at scale.

The cost for Enhanced Internet was the $40 subscription fee for QuitNet’s premium service. This fee reflects the actual per-person cost to commercial payers for a longstanding, fully developed and maintained website with a large social network and evidence-based cessation content. The cost of Enhanced Internet+Phone was $145 per participant, which reflects the charge from an established call centre working with a seamlessly integrated internet programme, and reflects ‘at-scale’ charges to deliver services to large numbers of individuals (eg, 100 000–200 000 users/year). Research costs were considered ‘sunk costs’ and were excluded from analyses.44

Analysis

We assessed the average cost per quitter and incremental net cost of each intervention arm per additional quitter for our base case. We repeated the average cost per quitter analysis using actual intervention adherence. For incremental analyses, we ordered intervention arms by their total costs, from least to most costly (Basic Internet, Enhanced Internet, Enhanced Internet+Phone, respectively). We used the following formula to estimate incremental cost-effectiveness ratios:

(TCx-TCy)/(TQx-TQy)

where TCx is the total cost of the intervention, TCy is the total cost of the next least expensive intervention, TQx is the number of quitters in the intervention, and TQy is the number of quitters in the next least expensive intervention. If an intervention is more costly and less effective than the next least expensive comparator, it is labelled ‘dominated’ and would not be considered.

RESULTS

Study sample

Mean age of the 2005 participants was 35.9 years (SD=10.8), 51.1% were women, and proportions of racial/ethnic minorities were similar to US smokers45 except that proportions of Hispanics and African–American men were slightly lower in this study than the general smoking population (table 1). There were no significant between-group differences on any baseline demographic or smoking variables.

Table 1.

Baseline characteristics of participants in The iQUITT Study

Demographic variables
Age, years, n (%) 35.9 (10.8)
Women, n (%) 1024 (51.1)
Education (highest grade completed), n (%)
 Grade 1–11 63 (3.14)
 Grade 12 or GED 381 (19.00)
 College 1–3 years 947 (47.24)
 College 4 years or more 614 (30.62)
Race, n (%)
 Caucasian 1735 (86.53)
 African–American 173 (8.63)
 Asian 62 (3.09)
 Native Hawaiian/other Pacific Islander 8 (0.40)
 American–Indian/Alaska Native 27 (1.35)
Hispanic, n (%) 81 (4.0)
Income,* n (%)
 <$30000 565 (28.33)
 $30000–$50000 567 (28.44)
 $50000–$75000 400 (20.06)
 >$75000 462 (23.17)
Marital status,* n (%)
 Married 814 (40.64)
 Cohabitating 309 (15.43)
 Single 405 (20.22)
 Separated 74 (3.69)
 Divorced 381 (19.02)
 Widowed 20 (1.00)
Employment status,* n (%)
 Full-time 1430 (71.39)
 Part-time 187 (9.34)
 Unemployed 111 (5.54)
 Homemaker 91 (4.54)
 Retired 42 (2.10)
 Student 142 (7.09)
US Region,* n (%)
 Northeast 359 (17.9)
 Midwest 558 (27.9)
 South 710 (35.5)
 West 374 (18.7)
Smoking variables
 Age first puff, mean (SD), year 14.21 (3.73)
 Age onset of daily smoking, mean (SD), year 17.19 (3.86)
 Daily smoking rate (cigarettes per day), mean (SD) 20.00 (9.96)
 # quit attempts past year,* mean (SD) 3.27 (8.00)
General internet use variables
 Duration of internet use,* n (%)
 Less than 1 year 40 (2.00)
 1–2 years 35 (1.75)
 2–5 years 331 (16.54)
 More than 5 years 1595 (79.71)
Frequency of internet use, n (%)
 Several times a day 1546 (77.11)
 About once a day 288 (14.36)
 3–5 days per week 119 (5.93)
 1–2 days per week 39 (1.95)
 Every few weeks or less often 13 (0.65)
Type of internet connection,* n (%)
 Dial-up connection 289 (14.45)
 Broadband connection 1711 (85.55)
*

Participants were able to refuse answering a question or respond ‘Don’t know’. Sample sizes are: income, n=1994; marital status, n=2003; employment status, n=2003; # quit attempts, n=1999; duration of internet use, n=2001; type of internet connection, n=2000; US region, n=2001.

Regions based on definition by the US Census Bureau, http://www.census.gov/geo/www/us_regdiv.pdf

Cessation outcomes

Using intention-to-treat analysis, 30-day SPP abstinence rates increased over time (table 2). Significant between-group differences in SPP were observed at 3, 6 and 12 months, but not at 18 months. Post hoc comparisons showed Enhanced Internet +Phone outperforming the other two conditions at 3 and 6 months, and Enhanced Internet at 12 months (p<0.003). The difference between Enhanced Internet and Basic Internet for SPP abstinence was not statistically significant at any follow-up.

Table 2.

Average costs per quitter in The iQUITT Study (Base case analysis)

Intervention arm and time point Number of participants Cost per person ($) SPP abstinence rate (%)* No of quitters Cost per quitter ($) MPP abstinence rate (%) No of quitters Cost per quitter ($)
3 months
 Basic Internet 679 1 9.1 62 11 9.1 62 11
 Enhanced Internet 651 40 10.4 68 383 10.4 68 383
 Enhanced Internet+phone 675 145 19.0 128 765 19.0 128 765
6 months
 Basic Internet 679 1 12.2 83 8 6.6 45 15
 Enhanced Internet 651 40 14.4 94 277 7.4 48 543
 Enhanced Internet+phone 675 145 19.7 133 736 12.4 84 1165
12 months
 Basic Internet 679 1 17.5 119 6 4.6 31 22
 Enhanced Internet 651 40 15.1 98 266 4.8 31 840
 Enhanced Internet+phone 675 145 21.5 145 675 9.5 64 1529
18 months
 Basic Internet 679 1 19.0 129 5 3.5 24 28
 Enhanced Internet 651 40 17.4 113 230 4.5 29 898
 Enhanced Internet+phone 675 145 19.6 132 741 7.7 52 1882
*

SPP abstinence rate: 30-day single-point prevalence abstinence.

Cost per quitter: total cost (number participants multiplied by cost per participant) divided by number of quitters.

MPP abstinence rate: 30-day multiple-point prevalence abstinence.

In contrast with SPP rates, 30-day MPP abstinence rates declined across groups over time (table 2) since, by definition, no subsequent MPP data point can ever exceed a prior data point. Significant between-group differences in MPP were observed at all follow-ups with Enhanced Internet+Phone outperforming the other conditions. The difference between Enhanced Internet and Basic Internet for MPP abstinence was not statistically significant at any time.

Average cost per quitter—base case analysis

The average cost per quitter at 3 months was $11 for Basic Internet, $383 for Enhanced Internet and $765 for Enhanced Internet+Phone (table 2). Using 30-day SPP abstinence, the average cost per quitter decreased over time across treatment groups, dropping to $5 for Basic Internet, $230 for Enhanced Internet and $741 for Enhanced Internet+Phone by 18 months. Using 30-day MPP abstinence, the cost per quitter increased over time, reaching $28 for Basic Internet, $898 for Enhanced Internet and $1882 for Enhanced Internet+Phone by 18 months.

Incremental costs per additional quitter

In the analysis of incremental cost per additional quitter (table 3), Enhanced Internet+Phone was the most cost-effective intervention at all follow-ups using both SPP and MPP abstinence. Compared with Enhanced Internet (the next least costly intervention), the cost per additional quitter for Enhanced Internet+Phone ranged from $1197 at 3 months to $3781 (SPP) and $3123 (MPP) at 18 months.

Table 3.

Incremental costs per additional quitter in The iQUITT Study

Intervention arm and time point Number of participants Cost per person ($) Total incremental cost ($)* SPP incremental # quitters Cost per additional quitter ($) MPP incremental #quitters Cost Per additional quitter ($)
3 months
 Basic Internet 679 1
 Enhanced Internet 651 40 25361 6 4227 6 4227
 Enhanced Internet+phone 675 145 71835 60 1197 60 1197
6 months
 Basic Internet 679 1
 Enhanced Internet 651 40 25361 11 2305 3 8453
 Enhanced Internet+phone 675 145 71835 39 1841 36 1995
12 months
 Basic Internet 679 1
 Enhanced Internet 651 40 25361 −21 Dominated 0 Dominated 3
 Enhanced Internet+phone 675 145 71835 47 1528 33 2176
18 months
 Basic Internet 679 1
 Enhanced Internet 651 40 25361 −16 Dominated 5 5072
 Enhanced Internet+phone 675 145 71835 19 3781 23 3123
*

Total incremental cost=(total # participants × cost per person) minus (total # participants × cost per person for the next less expensive intervention).

Cost per additional quitter=total incremental cost divided by incremental number of quitters.

‘Dominated’ means that the intervention costs more but is less effective than the next least expensive intervention.

Average cost per quitter—adherence analysis

Participants with higher levels of utilisation of each intervention had higher abstinence rates than those with lower utilisation (table 4). For Basic Internet, participants who spent 30+ min on the site were twice as likely to be abstinent (13.9% vs 5.4%). For Enhanced Internet, quit rates increased from 4.9% among those who spent no time on the site, to 14.6% among those who spent 30+ min, to 24.4% among those who spent 30+ min and sent messages to one or more QuitNet members. For Enhanced Internet+Phone, spending 30+ min on the site, sending internal messages to one or more QuitNet members, and completing 5+ calls, increased abstinence to 41.9%.

Table 4.

Average costs per quitter in The iQUITT Study (adherence analysis)

Number of participants Abstinence rate (%)* No of quitters Cost per person ($) Cost per quitter ($)
Base case analysis (from table 2 above)
 Basic Internet 679 9.1 62 1 11
 Enhanced Internet 651 10.4 68 40 383
 Enhanced Internet+phone 675 19.0 128 145 765
Adherence Scenario 1: no utilisation (time online=0 min, # people sent messages to=0, calls=0)
 Basic Internet 147 5.4 8 1 18
 Enhanced Internet 163 4.9 8 40 815
 Enhanced Internet+phone 68 5.9 4 145 2465
Adherence Scenario 2: increase in time online only (time online ≥30 min, # people sent messages to=0, calls=0)
 Basic Internet 108 13.9 15 1 7
 Enhanced Internet 199 14.6 29 40 274
 Enhanced Internet+phone 37 5.4 2 145 2683
Adherence Scenario 3: increase in time online+community participation (time online ≥30 min, # people sent messages to ≥1, calls=0)
 Basic Internet 108 13.9 15 1 7
 Enhanced Internet 82 24.4 20 40 164
 Enhanced Internet+phone 10 30.0 3 145 483
Adherence Scenario 4: increase in time online+telephone counselling (time online ≥30 min, # people sent messages to=0, calls ≥5)
 Basic Internet 108 13.9 15 1 7
 Enhanced Internet 199 14.6 29 40 274
 Enhanced Internet+phone 95 37.9 36 145 383
Adherence Scenario 5: OPTIMAL utilisation (time online ≥ 30 min, # people sent messages to ≥1, calls ≥5)
 Basic Internet 108 13.9 15 1 7
 Enhanced Internet 82 24.4 20 40 164
 Enhanced Internet+phone 62 41.9 26 145 346
*

30-day point prevalence abstinence at 3 months.

MPP, multiple-point prevalence; SPP, single-point prevalence.

Since there were intervention costs for all participants, regardless of utilisation as adherence increased, the cost per quitter dropped across all treatment arms. Cost-effectiveness was best among the subset of participants who used the ‘optimal’ level of all intervention components (Scenario 5, table 4). The average cost per quitter in Enhanced Internet +Phone dropped from $765 in the base case to $346 in the ‘optimal’ scenario. Likewise, the cost per quitter in Enhanced Internet dropped from $383 in the base to $164 in the ‘optimal’ scenario. Increasing time online made moderate contributions to cost-effectiveness across treatment arms (Scenario 2), but adding ‘optimal’ use of online social support/sending messages (Scenario 3) and telephone counselling (Scenario 4) to time online among those in the respective arms resulted in even greater cost-effectiveness compared with non-use (Scenario 2).

DISCUSSION

This is one of the first studies to integrate a cost-effectiveness analysis within a clinical trial of internet and telephone treatment for smoking cessation. The results demonstrate that internet alone, and combined internet and telephone treatments, can be considered cost-effective tobacco dependence treatment modalities. Basic Internet had the lowest cost per quitter at all time points. In the analysis of incremental costs per additional quitter, Enhanced Internet+Phone was more costly than Enhanced Internet alone, but was also more effective, and thus, is considered the most cost-effective approach using both abstinence metrics. Overall, all three interventions are cost-effective and can be used to make a meaningful public health impact at the population level. Adherence to the ‘optimal’ level of the interventions was important to obtaining even better cost-efficiency for any option chosen to increase quit rates. Optimal use of the interactive features of the internet and telephone counselling yielded the most cost-effective choices. Increasing time spent on the internet was not necessarily cost-effective without being supplemented by these interactive features.

Our results compare favourably with other cost-effectiveness studies of similar interventions. For instance, Tomson and colleagues15 reported telephone counselling costs of $1052–$1360 per quitter, defined as 7-day abstinence at 12 months (in 2004 US dollars). In our study, the cost per quit at 12 months using 30-day SPP abstinence was $266 for Enhanced Internet and $675 for Enhanced Internet+Phone. Even in the most conservative analyses using 30-day MPP, the cost per quit was $840 and $1529 for Enhanced Internet and Enhanced Internet+Phone, respectively. An and colleagues13 reported a cost per quit (defined as 30 days abstinence at 6 months) of $291 for internet and $1850 for telephone counselling, compared with our SPP results at the same time point of $277 for Enhanced Internet and $736 for Enhanced Internet+Phone. With a cost per quitter under $2000 for all interventions even using the most conservative MPP abstinence metric at 18 months, our results suggest that internet and combined internet and telephone treatments are cost-effective approaches to tobacco dependence treatment.40, 46

Analyses that stratified smokers according to differential utilisation of treatment services confirmed that treatment adherence is an important factor in determining treatment response (quitting) and cost-effectiveness. This finding is largely the consequence of the fact that there were increased quit rates observed with greater levels of adherence consistent with a dose-response relationship. These analyses may explain the equivalent performance of Basic Internet and Enhanced Internet in the parent trial,31 which is consistent with other studies that found no significant differences between static and interactive websites.4749 We are currently exploring these results in more detail, but these findings are consistent with prior research demonstrating the importance of adherence.24 Across all intervention arms, adherence to the ‘optimal’ level of the interventions was important to maximising cost-efficiency. Participation in the community and telephone counselling enhanced cost-effectiveness; increasing time spent on the internet was not necessarily cost-effective without being supplemented by these interactive features. The implication is that utilisation of the full range of intervention components in both internet and telephone interventions should be encouraged to realise maximal cost-efficiency.

Previous research suggests that the most effective cessation approaches combine treatment with supportive policies, media messages, and social and environmental supports.50 Strategies to promote adherence could include incentives, self-monitoring systems that stimulate return visits, personal contacts,51 social network approaches36 or systems-level interventions that leverage existing communication channels.52 None of the interventions in this trial had components or features specifically designed to maximise adherence. Indeed, like the majority of cessation treatments offered in the real world, the internet and telephone interventions in this study took a ‘buffet’ approach in that users self-selected which components they used. Overlaid on the intervention itself, strategies to increase adherence may incur their own costs. Thus, data are needed on the most effective and cost-efficient strategies to promote treatment adherence in the context of internet and telephone treatments.

Several limitations of this study should be considered. First, while the thresholds we selected to define ‘optimal’ adherence are based on empirical data,2,35,41 they are somewhat arbitrary since this is a new area of inquiry. These thresholds do not imply recommendations for treatment utilisation, but were designed to illustrate the cost implications of adherence. Second, commercial charges for the two intervention conditions were used rather than actual costs. However, these are the most relevant charges since they reflect the price to a payer (eg, large health plan), and are calculated at scales based on high-volume delivery. Third, we used known costs in a real-world commercial setting for Enhanced Internet, but developed an arbitrary estimate for Basic Internet. The cost per person to a payer to provide static web pages could be higher or lower depending on scale, institutional resources and the nature of the intervention. At public health scale (ie, hundreds of thousands of visitors every year), the costs of hosting static content would be in pennies per person, while the costs of creating a static site for a small business (<500 employees) might exceed several hundred dollars per person. Fourth, the cost per quitter using intention-to-treat analysis likely represents the most conservative estimate given that we included the intervention costs for participants assumed to be smoking. Finally, it is not clear to what degree our results obtained with a volunteer research sample generalise to the general population of smokers who use these treatments in other contexts.

Direct comparison of our results with published findings is challenging given the variability in the metrics of abstinence reported in other trials, the length of follow-up, the economic evaluation methods used and the study setting.40,53 Previous studies have used varying metrics for reporting costs, with some using average cost per quitter, and others (including ours) including both average cost per quitter and incremental cost-effectiveness.54 Since there are few economic analyses of internet interventions,44 we provide a range of cost results and abstinence metrics33 to inform decision makers and researchers interested in comparing our results with other studies.

Overall, this study demonstrates that internet and combined internet and telephone treatments are cost-effective, with relatively modest costs per quitter. Increased adherence to each of the interventions—taking advantage of major interactive components—further improved cost-effectiveness. Different modes of intervention may appeal to different smokers and, therefore, it is difficult to recommend one modality over another based solely on moderate differences in cost per quit. However, the results support the inclusion of scalable smoking cessation interventions, similar to those used in this study, into the healthcare delivery system where broad access and adherence could save lives and unnecessary smoking-attributable costs.

What this study adds.

  • This is one of the first studies to provide evidence regarding the cost-effectiveness of internet and combined internet and telephone interventions for smoking cessation. A static, information-only comparison website had the lowest cost per quitter at all time points.

  • In analyses of the incremental costs per additional quitter, the most cost-effective intervention was an interactive website with a large social network combined with proactive telephone counselling.

  • The unique contribution of this study is the focus of the critical role of adherence in cost-effectiveness studies. Payers wishing to optimise their investment in smoking cessation interventions delivered to large populations will need to address low rates of adherence in both internet and combined internet and telephone interventions.

  • Future research will need to identify the most effective and cost-efficient strategies to promote treatment adherence to maximise cessation outcomes.

Acknowledgments

The authors would like to acknowledge the contributions of Sarah Cha, MSPH, for her assistance in preparing the manuscript.

Funding Primary funding for this work was from the National Cancer Institute at the National Institutes of Health (RO1CA104836 to ALG). This work was also supported by grants U01CA088283, U01CA152958, and KO5CA96940 to JSM from the National Cancer Institute at the National Institutes of Health. The funding agency had no involvement in the conduct of the study or preparation of this manuscript.

Footnotes

Competing interests Cobb is a consultant to Healthways Inc, which operates QuitNet, a web-based smoking cessation application using social networks. Tinkelman is medical director of the National Jewish Health QuitLine, and vice president of Health Initiatives for National Jewish which owns the QuitLine.

Ethics approval Georgetown University institutional review board.

Provenance and peer review Not commissioned; externally peer reviewed.

Data sharing statement In the spirit of intellectual collaboration and to further pursue its mission, the American Legacy Foundation may, at its discretion, make available deidentified datasets. In the normal course, data sharing is restricted to recipients of federal grants; however, the Foundation will consider exceptions in particular circumstances.

Contributors ALG, NKC, DST, RSN, DBA: study concept; ALG, JSM: study design; ALG, NKC, DST: acquisition of data; ALG, YC, YF: statistical analysis; ALG, JSM: draft of manuscript; YC, YF, NKC, DST, RSN, DBA: comments on manuscript; ALG, NKC, DST, RSN, DBA: obtained funding.

References

  • 1.Centers for Disease Control and Prevention. Smoking-attributable mortality, years of potential life lost, and productivity losses—United States, 2000–2004. MMWR Morb Mortal Wkly Rep. 2008;57:1226–8. [PubMed] [Google Scholar]
  • 2.Fiore M, Jaén C, Baker T, et al. Treating tobacco use and dependence: 2008 Update. Clinical practice guideline. Rockville, MD: US Department of Health and Human Services, Public Health Service; 2008. [Google Scholar]
  • 3.Centers for Disease Control and Prevention. Trends in Current Cigarette Smoking Among High School Students and Adults, United States, 1965–2010. 2011. http://www.cdc.gov/tobacco/data_statistics/tables/trends/cig_smoking/index.htm (accessed Nov 2011).
  • 4.Institute of Medicine. Ending the tobacco problem: a blueprint for the nation. Washington, DC: The National Academies Press; 2007. [Google Scholar]
  • 5.Backinger CL, O’Connell ME. Developing consensus on tobacco control and research. Am J Prev Med. 2007;33:S311–13. doi: 10.1016/j.amepre.2007.09.012. [DOI] [PubMed] [Google Scholar]
  • 6.National Tobacco Cessation Collaborative. Innovations in Building Consumer Demand for Tobacco Cessation Products and Services. 2007 http://www.rwjf.org/files/publications/other/InnovationsinBuildingConsumerDemand.pdf.
  • 7.Pew Internet & American Life Project. Demographics of internet users. Washington, DC, 2012 http://www.pewinternet.org/Static-Pages/Trend-Data-%28Adults%29/Whos-Online.aspx (accessed 17 Sep 2012).
  • 8.Fox S. Health information online. Washington, DC: Pew Internet and American Life Project, 2005 http://www.pewinternet.org/~/media//Files/Reports/2005/PIP_Healthtopics_May05.pdf.pdf (accessed 5 Nov 2011).
  • 9.Fox S. Online Health Search 2006. 2006. http://www.pewinternet.org/~/media//Files/Reports/2006/PIP_Online_Health_2006.pdf.pdf (accessed 4 Dec 2011).
  • 10.Civljak M, Sheikh A, Stead LF, et al. Internet-based interventions for smoking cessation. Cochrane Database Syst Rev. 2010:CD007078. doi: 10.1002/14651858.CD007078.pub3. [DOI] [PubMed] [Google Scholar]
  • 11.Myung SK, McDonnell DD, Kazinets G, et al. Effects of web- and computer-based smoking cessation programs: meta-analysis of randomized controlled trials. Arch Int Med. 2009;169:929–37. doi: 10.1001/archinternmed.2009.109. [DOI] [PubMed] [Google Scholar]
  • 12.Shahab L, McEwen A. Online support for smoking cessation: a systematic review of the literature. Addiction. 2009;104:1792–804. doi: 10.1111/j.1360-0443.2009.02710.x. [DOI] [PubMed] [Google Scholar]
  • 13.An LC, Betzner A, Schillo B, et al. The comparative effectiveness of clinic, work-site, phone, and Web-based tobacco treatment programs. Nicotine Tob Res. 2010;12:989–96. doi: 10.1093/ntr/ntq133. [DOI] [PubMed] [Google Scholar]
  • 14.McAlister AL, Rabius V, Geiger A, et al. Telephone assistance for smoking cessation: one year cost effectiveness estimations. Tob Control. 2004;13:85–6. doi: 10.1136/tc.2003.004515. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Tomson T, Helgason AR, Gilljam H. Quitline in smoking cessation: a cost-effectiveness analysis. Int J Technol Assess Health Care. 2004;20:469–74. doi: 10.1017/s0266462304001370. [DOI] [PubMed] [Google Scholar]
  • 16.North American Quitline Consortium. All quitline facts. Phoenix, AZ: North American Quitline Consortium; 2009. http://www.naquitline.org/resource/resmgr/ql_about_facts/2008_quitline_facts_qa_final.pdf. [Google Scholar]
  • 17.Cummins SE, Bailey L, Campbell S, et al. Tobacco cessation quitlines in North America: a descriptive study. Tob Control. 2007;16(Suppl 1):i9–15. doi: 10.1136/tc.2007.020370. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Swan GE, McClure JB, Jack LM, et al. Behavioral counseling and varenicline treatment for smoking cessation. Am J Prev Med. 2010;38:482–90. doi: 10.1016/j.amepre.2010.01.024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Javitz HS, Zbikowski SM, Deprey M, et al. Cost-effectiveness of varenicline and three different behavioral treatment formats for smoking cessation. Transl Behav Med. 2011;1:182–90. doi: 10.1007/s13142-010-0009-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Zbikowski SM, Hapgood J, Smucker Barnwell S, et al. Phone and web-based tobacco cessation treatment: real-world utilization patterns and outcomes for 11,000 tobacco users. J Med Internet Res. 2008;10:e41. doi: 10.2196/jmir.999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Zbikowski SM, Jack LM, McClure JB, et al. Utilization of services in a randomized trial testing phone- and web-based interventions for smoking cessation. Nicotine Tob Res. 2011;13:319–27. doi: 10.1093/ntr/ntq257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Cleemput I, Kesteloot K, DeGeest S. A review of the literature on the economics of noncompliance. Room for methodological improvement. Health Policy. 2002;59:65–94. doi: 10.1016/s0168-8510(01)00178-6. [DOI] [PubMed] [Google Scholar]
  • 23.Rosen AB, Spaulding AB, Greenberg D, et al. Patient adherence: a blind spot in cost-effectiveness analyses? Am J Managed Care. 2009;15:626–32. [PubMed] [Google Scholar]
  • 24.DiMatteo MR. Variations in patients’ adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42:200–9. doi: 10.1097/01.mlr.0000114908.90348.f9. [DOI] [PubMed] [Google Scholar]
  • 25.World Health Organization. Adherence to long-term therapies: evidence for action. Geneva, Switzerland: World Health Organization, 2003. http://whqlibdoc.who.int/publications/2003/9241545992.pdf (accessed 2 Nov 2011)
  • 26.Christensen H, Griffiths KM, Farrer L. Adherence in internet interventions for anxiety and depression. J Med Internet Res. 2009;11:e13. doi: 10.2196/jmir.1194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Eysenbach G. The law of attrition. J Med Internet Res. 2005;7:e11. doi: 10.2196/jmir.7.1.e11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Danaher BG, Boles SM, Akers L, et al. Defining participant exposure measures in web-based health behavior change programs. J Med Internet Res. 2006;8:e15. doi: 10.2196/jmir.8.3.e15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Lichtenstein E, Zhu SH, Tedeschi GJ. Smoking cessation quitlines: an underrecognized intervention success story. Amer Psychol. 2010;65:252–61. doi: 10.1037/a0018598. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Burns EK, Levinson AH, Deaton EA. Factors in nonadherence to quitline services: smoker characteristics explain little. Health Educ Behav. doi: 10.1177/1090198111425186. Published Online First: 12 Jan 2012. [DOI] [PubMed] [Google Scholar]
  • 31.Graham AL, Cobb NK, Papandonatos GD, et al. A randomized trial of internet and telephone treatment for smoking cessation. Arch Int Med. 2011;171:46–53. doi: 10.1001/archinternmed.2010.451. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Graham AL, Bock BC, Cobb NK, et al. Characteristics of smokers reached and recruited to an internet smoking cessation trial: a case of denominators. Nicotine Tob Res. 2006;8:S43–8. doi: 10.1080/14622200601042521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Hughes JR, Keely JP, Niaura RS, et al. Measures of abstinence in clinical trials: issues and recommendations. Nicotine Tob Res. 2003;5:13–25. [PubMed] [Google Scholar]
  • 34.SRNT Subcommittee on Biochemical Verification. Biochemical verification of tobacco use and cessation. Nicotine Tob Res. 2002;4:149–59. doi: 10.1080/14622200210123581. [DOI] [PubMed] [Google Scholar]
  • 35.Cobb NK, Graham AL, Bock BC, et al. Initial evaluation of a real-world Internet smoking cessation system. Nicotine Tob Res. 2005;7:207–16. doi: 10.1080/14622200500055319. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Cobb N, Graham A, Abrams D. Social network structure of a large online community for smoking cessation. Am J Public Hlth. 2010;100:1282–9. doi: 10.2105/AJPH.2009.165449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Tunis SR, Stryer DB, Clancy CM. Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. JAMA. 2003;290:1624–32. doi: 10.1001/jama.290.12.1624. [DOI] [PubMed] [Google Scholar]
  • 38.Siegel JE, Weinstein MC, Russell LB, et al. Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine. JAMA. 1996;276:1339–41. doi: 10.1001/jama.276.16.1339. [DOI] [PubMed] [Google Scholar]
  • 39.Gold M, Seigel J, Russell L, et al. Cost-effectiveness in health and medicine. New York, NY: Oxford University Press; 1996. [Google Scholar]
  • 40.Ronckers S, Ament A. Cost-effectiveness of treatment for tobacco dependence: a systematic review of the evidence. Washington, DC: The World Bank/The World Health Organization; 2003. [Google Scholar]
  • 41.Stead LF, Perera R, Lancaster T. Telephone counselling for smoking cessation. Cochrane Database Syst Rev. 2006;3:CD002850. doi: 10.1002/14651858.CD002850.pub2. [DOI] [PubMed] [Google Scholar]
  • 42.Bock BC, Graham AL, Whiteley JA, et al. A review of web-assisted tobacco interventions (WATIs) J Med Internet Res. 2008;10:e39. doi: 10.2196/jmir.989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.McCausland KL, Curry LE, Mushro A, et al. Promoting a web-based smoking cessation intervention: implications for practice. Cases Public Health Commun Mark. 2011;5 Proc:3–26. [Google Scholar]
  • 44.Tate DF, Finkelstein EA, Khavjou O, et al. Cost effectiveness of internet interventions: review and recommendations. Ann Behav Med. 2009;38:40–5. doi: 10.1007/s12160-009-9131-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Pleis JR, Lucas JW. Summary health statistics for US adults: National Health Interview Survey, 2007. Vital Health Stat. 2009;240:1–159. [PubMed] [Google Scholar]
  • 46.Ronckers ET, Groot W, Ament AJ. Systematic review of economic evaluations of smoking cessation: standardizing the cost-effectiveness. Med Decis Mak: An Int J Soc Med Decis Mak. 2005;25:437–48. doi: 10.1177/0272989X05278431. [DOI] [PubMed] [Google Scholar]
  • 47.Pike KJ, Rabius V, McAlister A, et al. American Cancer Society’s QuitLink: randomized trial of internet assistance. Nicotine Tob Res. 2007;9:415–20. doi: 10.1080/14622200701188877. [DOI] [PubMed] [Google Scholar]
  • 48.Rabius V, Pike KJ, Wiatrek D, et al. Comparing internet assistance for smoking cessation: 13-month follow-up of a six-arm randomized controlled trial. J Med Internet Res. 2008;10:e45. doi: 10.2196/jmir.1008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Muñoz RF, Barrera AZ, Delucchi K, et al. International Spanish/English Internet smoking cessation trial yields 20% abstinence rates at 1 year. Nicotine Tob Res. 2009;11:1025–34. doi: 10.1093/ntr/ntp090. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Levy DT, Graham AL, Mabry PL, et al. Modeling the impact of smoking-cessation treatment policies on quit rates. Am J Prev Med. 2010;38:S364–72. doi: 10.1016/j.amepre.2009.11.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Bennett GG, Glasgow RE. The delivery of public health interventions via the Internet: actualizing their potential. Annu Rev Public Health. 2009;30:273–92. doi: 10.1146/annurev.publhealth.031308.100235. [DOI] [PubMed] [Google Scholar]
  • 52.Graham A, Cobb N, Raymond L, et al. Program: IBM Worksite Smoking Cessation Initiative. Health Educ Behav. 2006;33:125–27. [Google Scholar]
  • 53.Ruger JP, Lazar CM. Economic evaluation of pharmaco- and behavioral therapies for smoking cessation: a critical and systematic review of empirical research. Annu Rev Public Health. 2000;33:279–305. doi: 10.1146/annurev-publhealth-031811-124553. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Kahende JW, Loomis BR, Adhikari B, et al. A review of economic evaluations of tobacco control programs. Int J Environ Res Public Health. 2009;6:51–68. doi: 10.3390/ijerph6010051. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES